Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

2.64
Delayed Data
As of 3:01pm ET
 -0.12 / -4.35%
Today’s Change
1.69
Today|||52-Week Range
6.69
+2.33%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close2.76
Today’s open2.73
Day’s range2.63 - 2.73
Volume140,122
Average volume (3 months)931,250
Market cap$62.4M
Dividend yield--
Data as of 3:01pm ET, 05/06/2016

Growth & Valuation

Earnings growth (last year)+56.50%
Earnings growth (this year)+15.98%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+77.69%
P/E ratioNM
Price/Sales1.20
Price/Book--

Competitors

 Today’s
change
Today’s
% change
REPHRecro Pharma Inc+0.07+1.05%
OCRXOcera Therapeutics I...-0.04-1.19%
CASICASI Pharmaceuticals...-0.02-1.36%
AVIRAviragen Therapeutic...-0.06-3.70%
Data as of 2:50pm ET, 05/06/2016

Financials

Next reporting dateMay 13, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$51.2M
Annual profit (last year)-$16.3M
Net profit margin-31.93%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs